Internal Medicine, Pulmonary Disease · Chicago, IL
NPI
1770900185
Since 2014
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
675 N Saint Clair St Ste 18-250
Chicago, IL, 60611
Phone (312) 695-1800
Groups this clinician bills Medicare through
Medicare paid, 2024
$124K
1,566 services
Medicare patients, 2024
342
Average age 74
Drug cost, 2024
$2.2M
917 prescriptions
Company payments, 2025
$19K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anthony J Esposito was code 99215 (office e&m - established), 219 times for 159 patients. In total Anthony J Esposito billed 1,566 services in 33 codes, and Medicare paid $124K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 219 | 159 | $142.77 | $31K |
| 99291 Critical Care E&M | Facility | 205 | 77 | $177.05 | $36K |
| 94729 Pulmonary Function Testing | Office | 166 | 138 | $44.14 | $7,327 |
| 94375 Pulmonary Function Testing | Office | 161 | 135 | $30.63 | $4,931 |
| 94726 Pulmonary Function Testing | Office | 155 | 132 | $44.10 | $6,835 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 152 | 120 | $13.37 | $2,032 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 101 | 57 | $26.02 | $2,628 |
| 99214 Office E&M - Established | Office | 97 | 83 | $97.78 | $9,485 |
| 94618 Pulmonary Function Testing | Office | 75 | 74 | $26.64 | $1,998 |
| 99233 Hospital E&M - Subsequent | Facility | 39 | 33 | $97.28 | $3,794 |
| 36620 Vascular | Facility | 23 | 20 | $36.58 | $841 |
| 99205 Office E&M - New | Office | 21 | 21 | $182.76 | $3,838 |
| G0008 Administration of influenza virus vaccine | Office | 17 | 16 | $33.70 | $573 |
| G0009 Administration of pneumococcal vaccine | Office | 17 | 17 | $33.70 | $573 |
| 90677 Vaccine Product | Office | 17 | 17 | $291.54 | $4,956 |
By year: 2022 $101K for 945 services; 2023 $130K for 1,389 services; 2024 $124K for 1,566 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anthony J Esposito prescribed most often to Medicare patients was Ofev (Nintedanib Esylate), with 149 prescriptions and refills. In total Anthony J Esposito wrote 917 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ofev Nintedanib Esylate | 149 | 149 | 18 | $1.9M |
| Mycophenolate Mofetil Generic | 138 | 203 | 29 | $17K |
| Omeprazole Generic | 101 | 229 | 30 | $1,256 |
| Pirfenidone Generic | 73 | 77 | Under 11 | $151K |
| Gabapentin Generic | 60 | 68 | 16 | $497 |
| Mycophenolic Acid Mycophenolate Sodium | 40 | 68 | Under 11 | $26K |
| Pantoprazole Sodium Generic | 40 | 74 | 11 | $457 |
| Prednisone Generic | 37 | 45 | 22 | $206 |
| Breo Ellipta Fluticasone/Vilanterol | 37 | 39 | Under 11 | $14K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 29 | 33 | Under 11 | $21K |
| Famotidine Generic | 27 | 46 | Under 11 | $250 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 20 | 29 | 12 | $51.44 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 19 | 21 | Under 11 | $592 |
| Advair Hfa Fluticasone Propion/Salmeterol | 19 | 25 | Under 11 | $9,636 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 16 | 22 | Under 11 | $3,314 |
Brand drugs: 317 claims; generic drugs: 600 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anthony J Esposito $19K ($19K in general payments such as food, travel and fees) from 8 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $11K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.